4Pasquier F, Henon H, Leys D. Relevance of white matter changes to pre- and poststroke dementia. Ann N Y Acad Sci, 2000, 903(2):466 - 469.
5Leys D, Englund E, Del Ser T, et al. White matter changes in stroke patients. Relationship with stroke subtype and outcome. Eur Neurol,1999, 42(1): 67-75.
6Regeur L. Increasing loss of brain tissue with increasing dementia: a stereological study of post- mortem brains from elderly females. Eur J Neurol, 2000, 7(1): 47-54.
7Double KL, Halliday GM, Kril JJ, et al. Topography of brain atrophy during normal aging and Alzheimer' s disease. Neurobiol Aging, 1996,17(4): 513 - 521.
[5]Filley CM. The behavioral neurology of cerebral white matter. Neurology, 1998, 50(6): 1535- 1540.
8Esiri MM Which vascular lesions are of importance in vascular dementia?Ann N Y Acad Sci, 2000, 903(1): 239-243.
9Hargrave R, Geck LC, Reed B, et al. Affective behavioural disturbances in Alzheimer' s disease and ischaemic vascular disease. J Neurol Neurosurg Psychiatry, 2000, 68( 1 ): 41 - 46.
10Parnetti L. Pathophysiology of vascular dementia and white matter changes. Rev Neurol, 1999, 155(9): 754-758.
2Ellis R J, Jan K, Kawas C, et al. Diagnostic validity of the dementia questionnaire for Alzheimer disease. Arch Neurol 1998; 55:360 - 5.
3Binetti G, Locascio J J, Corkin S, et al. Differences between Pick disease and Alzheimer disease in clinical appearance and rate of cognitive decline. Arch Neurol 2000; 57 (2) : 225 - 32.
4Tiemey MC, Szalai JP, Snow WG, et al. Domain specificity of the subtests of the mini mental state examination. Arch Neurol 1997; 54:713 - 6.
5Stuss DT, Meiran N, Guzman DA, et al. Do long tests yield a more accurate diagnosis of dementia than short tests? Arch Neurol 1996; 53:1033 -9.
6Kupke T, Revis ES, Gantner AB. Hemispheric bias of the Mini-Mental State Examination in elderly males. Clin Neuropsychol 1993; 7:210 -4.
7Bowie P, Branton T, Holmes J. Should the Mini Mental State Examination be used to monitor dementia treatments? Lancet 1999; 354(9189): 1527 - 8.
8Solomon PR, Hirschoff A. A 7 minute neurocognitive screening battery highly sensitive to Alzheimer' s disease. Arch Neurol 1998; 55 (3) : 349 - 55.
9Tsolaki M, lakovidou V, Papadopoulou E, et al. Greek validation of the seven-minute screening battery for Alzheimer' s disease in the elderly. Am J Alzheimers Dis Other Demen 2002; 17 (3) : 139 - 48.
10Jorm AF. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (1QCODE) : development and cross-validation. Psychol Med 1994; 24 ( 1 ) :145 - 53.
